APA (7th ed.) Citation

C, B., F, F., A, D., M, F., G, R., M, T., . . . C, S. (2025). Elexacaftor/tezacaftor/ivacaftor (ETI) therapy modifies the expression of interferon beta and inflammatory genes in the airways of adult patients with cystic fibrosis: A pilot study. Molecular and cellular biochemistry, 480(10), 5521. https://doi.org/10.1007/s11010-025-05331-x

Chicago Style (17th ed.) Citation

C, Bitossi, et al. "Elexacaftor/tezacaftor/ivacaftor (ETI) Therapy Modifies the Expression of Interferon Beta and Inflammatory Genes in the Airways of Adult Patients with Cystic Fibrosis: A Pilot Study." Molecular and Cellular Biochemistry 480, no. 10 (2025): 5521. https://doi.org/10.1007/s11010-025-05331-x.

MLA (9th ed.) Citation

C, Bitossi, et al. "Elexacaftor/tezacaftor/ivacaftor (ETI) Therapy Modifies the Expression of Interferon Beta and Inflammatory Genes in the Airways of Adult Patients with Cystic Fibrosis: A Pilot Study." Molecular and Cellular Biochemistry, vol. 480, no. 10, 2025, p. 5521, https://doi.org/10.1007/s11010-025-05331-x.